These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

751 related items for PubMed ID: 26342592

  • 1. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
    Ito R, Iwano S, Kishimoto M, Ito S, Kato K, Naganawa S.
    Ann Nucl Med; 2015 Dec; 29(10):897-905. PubMed ID: 26342592
    [Abstract] [Full Text] [Related]

  • 2. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
    Zhao SJ, Wu N, Zheng R, Liu Y, Zhang WJ, Liang Y, Zhang H, Li XM.
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.
    Wang Y, Ma S, Dong M, Yao Y, Liu K, Zhou J.
    BMC Pulm Med; 2015 Mar 08; 15():20. PubMed ID: 25880540
    [Abstract] [Full Text] [Related]

  • 4. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
    Muto J, Hida Y, Kaga K, Ohtaka K, Okamoto S, Tamaki N, Nakada-Kubota R, Hirano S, Matsui Y.
    Anticancer Res; 2014 Feb 08; 34(2):805-10. PubMed ID: 24511016
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Feb 08; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 6. Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT.
    Kishimoto M, Iwano S, Ito S, Kato K, Ito R, Naganawa S.
    Lung Cancer; 2014 Nov 08; 86(2):180-4. PubMed ID: 25263854
    [Abstract] [Full Text] [Related]

  • 7. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
    Park SY, Yoon JK, Park KJ, Lee SJ.
    Cancer Imaging; 2015 Dec 22; 15():21. PubMed ID: 26694918
    [Abstract] [Full Text] [Related]

  • 8. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
    Nakamura H, Saji H, Marushima H, Kimura H, Tagaya R, Kurimoto N, Hoshikawa M, Takagi M.
    Ann Surg Oncol; 2015 Dec 22; 22 Suppl 3():S1388-93. PubMed ID: 25900205
    [Abstract] [Full Text] [Related]

  • 9. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J.
    Clin Lung Cancer; 2013 Sep 22; 14(5):568-73. PubMed ID: 23835164
    [Abstract] [Full Text] [Related]

  • 10. Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.
    Chiu CH, Yeh YC, Lin KH, Wu YC, Lee YC, Chou TY, Tsai CM.
    J Thorac Oncol; 2011 Oct 22; 6(10):1697-703. PubMed ID: 21869716
    [Abstract] [Full Text] [Related]

  • 11. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH, Choi JY, Kim K, Kim J, Shim YM, Um SW, Kim H, Lee KH, Kim BT.
    Ann Surg; 2013 Feb 22; 257(2):364-70. PubMed ID: 22968069
    [Abstract] [Full Text] [Related]

  • 12. Relationship between primary lesion FDG uptake and clinical stage at PET-CT for non-small cell lung cancer patients: An observation.
    Li M, Sun Y, Liu Y, Han A, Zhao S, Ma L, Zheng J, Yu J.
    Lung Cancer; 2010 Jun 22; 68(3):394-7. PubMed ID: 19683358
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 22; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.